Phibro Animal Health Corporation Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Phibro Animal Health Corporation (PAHC) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $385.48 million as of 2026-06-30, per its 10-K filed 2026-08-26.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-26
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $385.48M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $361.83M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $332.36M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $311.68M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2026-06-30 | $385.48M 10-K · filed 2026-08-26 |
| 2026-03-31 | $361.83M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $332.36M 10-Q · filed 2026-05-06 |
| 2025-09-30 | $311.68M 10-Q · filed 2026-05-06 |
| 2025-06-30 | $285.68M 10-K · filed 2026-08-26 |
| 2025-03-31 | $265.99M 10-Q · filed 2026-05-06 |
| 2024-12-31 | $246.80M 10-Q · filed 2026-05-06 |
| 2024-09-30 | $258.53M 10-Q · filed 2026-05-06 |
| 2024-06-30 | $256.64M 10-K · filed 2026-08-26 |
| 2024-03-31 | $270.09M 10-Q · filed 2025-05-07 |
| 2023-12-31 | $270.80M 10-Q · filed 2025-05-07 |
| 2023-09-30 | $273.07M 10-Q · filed 2025-05-07 |
| 2023-06-30 | $282.51M 10-K · filed 2026-08-26 |
| 2023-03-31 | $272.33M 10-Q · filed 2024-05-08 |
| 2022-12-31 | $268.37M 10-Q · filed 2024-05-08 |
| 2022-09-30 | $262.76M 10-Q · filed 2024-05-08 |
| 2022-06-30 | $262.44M 10-K · filed 2025-08-27 |
| 2022-03-31 | $266.94M 10-Q · filed 2023-05-03 |
| 2021-12-31 | $239.29M 10-Q · filed 2023-05-03 |
| 2021-09-30 | $233.31M 10-Q · filed 2023-05-03 |
| 2021-06-30 | $238.53M 10-K · filed 2024-08-28 |
| 2020-06-30 | $188.20M 10-K · filed 2023-08-30 |